CTI BioPharma
CTIC
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)
Categories
Market capitalization of CTI BioPharma (CTIC)
Market cap: $1.19 Billion
As of April 2024 CTI BioPharma has a market cap of $1.19 Billion. This makes CTI BioPharma the world's 4864th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CTI BioPharma from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.19 B | 0% |
| 2023 | $1.19 B | 57.19% |
| 2022 | $0.76 B | 218.03% |
| 2021 | $0.23 B | -1.88% |
| 2020 | $0.24 B | 166.78% |
| 2019 | $91.6 M | 115.35% |
| 2018 | $42.53 M | -63.06% |
| 2017 | $0.11 B | 0.08% |
| 2016 | $0.11 B | -66.65% |
| 2015 | $0.34 B | -17.31% |
| 2014 | $0.41 B | 50.1% |
| 2013 | $0.27 B | 94.66% |
| 2012 | $0.14 B | -36.15% |
| 2011 | $0.22 B | -24.72% |
| 2010 | $0.29 B | -55.86% |
| 2009 | $0.67 B | 8121.38% |
| 2008 | $8.18 M | -91.53% |
| 2007 | $96.63 M | -61.82% |
| 2006 | $0.25 B | 61.62% |
| 2005 | $0.15 B | -68.47% |
| 2004 | $0.49 B | 68.55% |
| 2003 | $0.29 B | 24.03% |
| 2002 | $0.23 B | -70.83% |
| 2001 | $0.81 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $202.12 B | 16,760.60% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $689.18 B | 57,389.82% | 🇺🇸 USA |
 Amgen AMGN | $144.48 B | 11,952.91% | 🇺🇸 USA |
 Baxter BAX | $20.49 B | 1,609.31% | 🇺🇸 USA |
 Incyte INCY | $11.49 B | 858.57% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.59 B | 7,457.31% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $15.00 B | 1,151.89% | 🇮🇱 Israel |